Filing Details
Nurix Therapeutics, Inc. (NASDAQ:NRIX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 09, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:NRIX
Nurix Therapeutics, Inc. (NRIX) Files Quarterly Report for Q0
Filing Details Nurix Therapeutics, Inc. (NASDAQ:NRIX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 09, 2026. The Healthcare company…
Market Context
Nurix Therapeutics, Inc.'s stock currently trades at $24.69 with a market capitalization of $1.5B.
The 10-Q provides Nurix Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Nurix Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NRIX Stock Page
Frequently Asked Questions
Where can I read NRIX's SEC filings?
Browse all filings on our NRIX SEC filings page.
What types of SEC filings does Nurix Therapeutics, Inc. file?
Public companies like Nurix Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.